John hubbard bioclinica. Prior to joining BioClinica, Dr. Hubbard brings more than three decades of experience across multiple senior executive roles with the industry’s foremost organizations. Over John Hubbard, Ph. Hubbard was previously the President and Chief Executive Officer of Bioclinica, a leading provider of medical imaging, clinical technology, and development services. , where he has served as senior vice president and worldwide head of development operations. , FCP, as chief executive officer Sep 2, 2020 · Dr. About John Hubbard, Ph. Hubbard served as Senior Vice President and Worldwide Head of Development Operations for Pfizer Inc. We experienced tremendous growth under our prior ownership and look forward to leveraging the strategic leadership and investment that will come with Cinven. As my “life/work” balance scale became severely tipped out of whack, I found myself reflecting upon past conversations with John Hubbard, and his image of calm. Mar 13, 2023 · Dr. , where he directed and oversaw clinical trial operations and management of more than 450 clinical projects. He is a leader in the Clinical Services and Biopharmaceutical R&D industries, with over three decades of experience including executive level positions at Pfizer, ICON, Parexel and Hoechst Marion Roussel Pharmaceuticals. He was responsible for global drug development of more than 450 clinical trials. John was President and CEO of Bioclinica, a leading provider of medical imaging, clinical technology and global clinical site network development services. Dr. John Hubbard ’78 has been appointed CEO of BioClinica, a leading provider of specialty outsourced clinical trial services. , a leading provider of specialized technology, medical imaging, and clinical trial services. Dec 15, 2014 · NEWTOWN, Pa. , a leading provider of specialty outsourced clinical trial services, announced today that it has appointed John Hubbard, Ph. Hubbard, 58, will join the company from Pfizer Inc. Prior to joining Science 37, John was the President and Chief Executive Officer of Bioclinica, Inc. Hubbard was most recently President and Chief Executive Officer of Bioclinica, Inc. He was the President and Chief Executive Officer of Bioclinica, a leading provider of medical imaging, clinical technologies and development services. -- BioClinica®, Inc. Prior to Bioclinica, he was Senior Vice President and Worldwide Head of Development Operations at Pfizer. Bioclinica's current President is John Hubbard. , FCP, is a member of Genstar’s Strategic Advisory Board, advising the firm in the area of healthcare. , Bioclinica President and CEO, said: “We are extremely excited about this new partnership with Cinven and see great things on the horizon for Bioclinica. John Hubbard is the President and CEO of Bioclinica. A seasoned pharmaceutical executive, Dr. John has more than 34 years of leadership experience in the biopharmaceutical and pharma services industries. May 7, 2018 · Dr. D. […]. Hubbard, who has over 32 years of experience in the biopharma and pharma services industries, will advise the firm on investments in the healthcare sector. Most recently, he was President and Chief Executive Officer at Bioclinica, a leading medical imaging and technology-enabled clinical services provider. He is also a member of the company’s board of directors. Bioclinica Management Team 26 Team Members Bioclinica has 26 executives. Most recently, he was President and CEO of Bioclinica, a leading provider of medical imaging and clinical technologies. px0 z7ew5p urz ji83 rgv 3bl q4o cyk nls6 tw